236 related articles for article (PubMed ID: 33143511)
1. Maternal high-dose valacyclovir and its correlation with newborn blood viral load and outcome in congenital cytomegalovirus infection.
Goncé A; Hawkins-Villarreal A; Salazar L; Guirado L; Marcos MA; Pascual Mancho J; Prats P; López M; Eixarch E; Salvia MD; Fortuny C; Figueras F
J Matern Fetal Neonatal Med; 2022 Oct; 35(20):4004-4008. PubMed ID: 33143511
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
D'Antonio F; Marinceu D; Prasad S; Khalil A
Ultrasound Obstet Gynecol; 2023 Apr; 61(4):436-444. PubMed ID: 36484439
[TBL] [Abstract][Full Text] [Related]
3. New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.
Egloff C; Sibiude J; Vauloup-Fellous C; Benachi A; Bouthry E; Biquard F; Hawkins-Villarreal A; Houhou-Fidouh N; Mandelbrot L; Vivanti AJ; Picone O
Ultrasound Obstet Gynecol; 2023 Jan; 61(1):59-66. PubMed ID: 35900718
[TBL] [Abstract][Full Text] [Related]
4. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
Leruez-Ville M; Ghout I; Bussières L; Stirnemann J; Magny JF; Couderc S; Salomon LJ; Guilleminot T; Aegerter P; Benoist G; Winer N; Picone O; Jacquemard F; Ville Y
Am J Obstet Gynecol; 2016 Oct; 215(4):462.e1-462.e10. PubMed ID: 27083761
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.
Faure-Bardon V; Fourgeaud J; Stirnemann J; Leruez-Ville M; Ville Y
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):576-581. PubMed ID: 33998084
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis.
Leruez-Ville M; Stirnemann J; Sellier Y; Guilleminot T; Dejean A; Magny JF; Couderc S; Jacquemard F; Ville Y
Am J Obstet Gynecol; 2016 Sep; 215(3):342.e1-9. PubMed ID: 27063062
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease.
De la Calle M; Baquero-Artigao F; Rodríguez-Molino P; Cabanes M; Cabrera M; Antolin E; Mellado MJ; Bartha JL
J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3196-3200. PubMed ID: 32933353
[TBL] [Abstract][Full Text] [Related]
8. Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series.
De Santis M; Apicella M; De Luca C; D'Oria L; Valentini P; Sanguinetti M; Lanzone A; Scambia G; Santangelo R; Masini L
J Clin Virol; 2020 Jun; 127():104351. PubMed ID: 32325395
[TBL] [Abstract][Full Text] [Related]
9. Recurrent congenital cytomegalovirus infection in a sequential pregnancy with severe sequelae, and a possible association with prophylactic valacyclovir treatment: a case report.
Brosh-Nissimov T; Benshalom-Tirosh N; Bucris E; Morad H; Zuckerman NS; Tepperberg Oikawa M
Int J Infect Dis; 2022 Dec; 125():93-95. PubMed ID: 36229004
[TBL] [Abstract][Full Text] [Related]
10. Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome.
Lazzarotto T; Gabrielli L; Foschini MP; Lanari M; Guerra B; Eusebi V; Landini MP
Pediatrics; 2003 Aug; 112(2):e153-7. PubMed ID: 12897321
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
[TBL] [Abstract][Full Text] [Related]
12. Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.
Codaccioni C; Vauloup-Fellous C; Letamendia E; Saada J; Benachi A; Vivanti AJ
J Gynecol Obstet Hum Reprod; 2019 Apr; 48(4):287-289. PubMed ID: 30634004
[TBL] [Abstract][Full Text] [Related]
13. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Amniotic Fluid Viral Load to Predict Adverse Outcome in Pregnancies Complicated by Congenital Cytomegalovirus Infection: A Multicenter Study.
Mappa I; D'Antonio F; Khalil A; De Vito M; Alameddine S; Capannolo G; di Mascio D; Rizzo G;
Fetal Diagn Ther; 2023; 50(1):1-7. PubMed ID: 36623501
[TBL] [Abstract][Full Text] [Related]
15. The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis.
Chatzakis C; Shahar-Nissan K; Faure-Bardon V; Picone O; Hadar E; Amir J; Egloff C; Vivanti A; Sotiriadis A; Leruez-Ville M; Ville Y
Am J Obstet Gynecol; 2024 Feb; 230(2):109-117.e2. PubMed ID: 37473793
[TBL] [Abstract][Full Text] [Related]
16. Revisiting short- and long-term outcome after fetal first-trimester primary cytomegalovirus infection in relation to prenatal imaging findings.
Lipitz S; Elkan Miller T; Yinon Y; Weissbach T; De-Castro H; Hoffman C; Katorza E; Weisz B
Ultrasound Obstet Gynecol; 2020 Oct; 56(4):572-578. PubMed ID: 31858642
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic CMV infection at birth following maternal primary infection despite valacyclovir treatment and a subsequent negative amniocentesis. Case report.
Toti MS; Zammarchi L; Pasquini L; Campolmi I; Modi G; Borchi B; Bartoloni A; Trotta M; Galli L; Bernardini R
Eur J Obstet Gynecol Reprod Biol; 2023 Dec; 291():128-130. PubMed ID: 37871349
[TBL] [Abstract][Full Text] [Related]
18. First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS.
Faure-Bardon V; Fourgeaud J; Guilleminot T; Magny JF; Salomon LJ; Bernard JP; Leruez-Ville M; Ville Y
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):568-572. PubMed ID: 33533526
[TBL] [Abstract][Full Text] [Related]
19. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
Kagan KO; Enders M; Hoopmann M; Geipel A; Simonini C; Berg C; Gottschalk I; Faschingbauer F; Schneider MO; Ganzenmueller T; Hamprecht K
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):560-567. PubMed ID: 33491819
[TBL] [Abstract][Full Text] [Related]
20. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
